Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) EBT (2020 - 2025)

Historic EBT for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to -$11.5 million.

  • Rapid Micro Biosystems' EBT fell 165.34% to -$11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$44.3 million, marking a year-over-year increase of 843.95%. This contributed to the annual value of -$46.9 million for FY2024, which is 1062.06% up from last year.
  • As of Q3 2025, Rapid Micro Biosystems' EBT stood at -$11.5 million, which was down 165.34% from -$11.8 million recorded in Q2 2025.
  • Rapid Micro Biosystems' 5-year EBT high stood at -$9.7 million for Q4 2024, and its period low was -$25.0 million during Q3 2021.
  • Moreover, its 5-year median value for EBT was -$13.4 million (2023), whereas its average is -$14.1 million.
  • In the last 5 years, Rapid Micro Biosystems' EBT crashed by 19564.24% in 2021 and then soared by 3458.57% in 2022.
  • Quarter analysis of 5 years shows Rapid Micro Biosystems' EBT stood at -$14.6 million in 2021, then fell by 12.83% to -$16.4 million in 2022, then soared by 32.09% to -$11.2 million in 2023, then grew by 13.34% to -$9.7 million in 2024, then dropped by 18.83% to -$11.5 million in 2025.
  • Its EBT was -$11.5 million in Q3 2025, compared to -$11.8 million in Q2 2025 and -$11.3 million in Q1 2025.